NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough ~ Statistically significant and clinically relevant improvements in patient reported outcomes in refractory chronic cough ~ Findings support further development of...
AXO-Lenti-PD was observed to be generally well tolerated at six months, and continued to demonstrate benefits in both patients across multiple measures after a single administration Totality of data across the program at 6 months supports overall favorable product...
ClinOne, a mobile clinical trial management solution, now provides integration with Uber Health to offer simple transportation services for patients enrolled in clinical trials. ClinicalTrialConnect, ClinOne’s patient-facing concierge platform, manages patients’...
Making it Easier for Pancreatic Cancer Patients to Pursue Clinical Trials Let’s Win! Pancreatic Cancer announces an expanded Clinical Trials section of the website. The enhancements include a dedicated clinical trials matching service for pancreatic cancer...
A single ILUVIEN implant significantly delayed recurrence and reduced uveitis symptoms upon recurrence compared to active control arm Recently approved in Europe, ILUVIEN is expected to launch in certain EU countries during the second half of 2019 ATLANTA, June 06,...
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) today announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory systemic light-chain (AL) amyloidosis did not meet the first of two primary endpoints. Treatment with...
Email
Text